Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials
Author:
Elmar A Joura,Sepp Leodolter,Mauricio Hernandez-Avila,Cosette M Wheeler,Gonzalo Perez,Laura A Koutsky,Suzanne M Garland,Diane M Harper,Grace WK Tang,Daron G Ferris,Marc Steben,Ronald W Jones,Janine Bryan,Frank J Taddeo,Oliver M Bautista et al.
Copyright © 2007 Elsevier Ltd. All rights reserved.